178 related articles for article (PubMed ID: 34560228)
21. The osteoporosis risk variant rs9820407 at 3p22.1 acts as an allele-specific enhancer to regulate CTNNB1 expression by long-range chromatin loop formation.
Wang Y; Lu L; Niu Y; Zhang Q; Cheng C; Huang H; Huang X; Huang Q
Bone; 2021 Dec; 153():116165. PubMed ID: 34461284
[TBL] [Abstract][Full Text] [Related]
22. A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.
Tao S; Wang Z; Feng J; Hsu FC; Jin G; Kim ST; Zhang Z; Gronberg H; Zheng LS; Isaacs WB; Xu J; Sun J
Carcinogenesis; 2012 Mar; 33(3):598-603. PubMed ID: 22219177
[TBL] [Abstract][Full Text] [Related]
23. CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants.
Spisák S; Lawrenson K; Fu Y; Csabai I; Cottman RT; Seo JH; Haiman C; Han Y; Lenci R; Li Q; Tisza V; Szállási Z; Herbert ZT; Chabot M; Pomerantz M; Solymosi N; ; Gayther SA; Joung JK; Freedman ML
Nat Med; 2015 Nov; 21(11):1357-63. PubMed ID: 26398868
[TBL] [Abstract][Full Text] [Related]
24. Exploring the effects of genetic variation on gene regulation in cancer in the context of 3D genome structure.
Osman N; Shawky AE; Brylinski M
BMC Genom Data; 2022 Feb; 23(1):13. PubMed ID: 35176995
[TBL] [Abstract][Full Text] [Related]
25. Integrative Genomic Analysis Predicts Causative
Zhang Y; Manjunath M; Zhang S; Chasman D; Roy S; Song JS
Cancer Res; 2018 Apr; 78(7):1579-1591. PubMed ID: 29351903
[TBL] [Abstract][Full Text] [Related]
26. Genetic factors regulating inflammation and DNA methylation associated with prostate cancer.
Ianni M; Porcellini E; Carbone I; Potenzoni M; Pieri AM; Pastizzaro CD; Benecchi L; Licastro F
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):56-61. PubMed ID: 22850906
[TBL] [Abstract][Full Text] [Related]
27. Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.
Wang X; Hayes JE; Xu X; Gao X; Mehta D; Lilja HG; Klein RJ
Gene; 2021 Feb; 768():145265. PubMed ID: 33122083
[TBL] [Abstract][Full Text] [Related]
28. Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer.
Guo H; Ahmed M; Zhang F; Yao CQ; Li S; Liang Y; Hua J; Soares F; Sun Y; Langstein J; Li Y; Poon C; Bailey SD; Desai K; Fei T; Li Q; Sendorek DH; Fraser M; Prensner JR; Pugh TJ; Pomerantz M; Bristow RG; Lupien M; Feng FY; Boutros PC; Freedman ML; Walsh MJ; He HH
Nat Genet; 2016 Oct; 48(10):1142-50. PubMed ID: 27526323
[TBL] [Abstract][Full Text] [Related]
29. Association of THADA, FOXP4, GPRC6A/RFX6 genes and 8q24 risk alleles with prostate cancer in Northern Chinese men.
Li XH; Xu Y; Yang K; Shi JJ; Zhang X; Yang F; Yuan H; Zhu X; Zhang YH; Wang JY; Yang Z
J BUON; 2015; 20(5):1223-8. PubMed ID: 26537068
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide association analysis reveals regulation of at-risk loci by DNA methylation in prostate cancer.
Liu Q; Liu G; Martin DT; Xing YT; Weiss RM; Qi J; Kang J
Asian J Androl; 2021; 23(5):472-478. PubMed ID: 33762478
[TBL] [Abstract][Full Text] [Related]
31. Identification of breast cancer associated variants that modulate transcription factor binding.
Liu Y; Walavalkar NM; Dozmorov MG; Rich SS; Civelek M; Guertin MJ
PLoS Genet; 2017 Sep; 13(9):e1006761. PubMed ID: 28957321
[TBL] [Abstract][Full Text] [Related]
32. Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease.
Selvarajan I; Toropainen A; Garske KM; López Rodríguez M; Ko A; Miao Z; Kaminska D; Õunap K; Örd T; Ravindran A; Liu OH; Moreau PR; Jawahar Deen A; Männistö V; Pan C; Levonen AL; Lusis AJ; Heikkinen S; Romanoski CE; Pihlajamäki J; Pajukanta P; Kaikkonen MU
Am J Hum Genet; 2021 Mar; 108(3):411-430. PubMed ID: 33626337
[TBL] [Abstract][Full Text] [Related]
33. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.
Oldridge DA; Wood AC; Weichert-Leahey N; Crimmins I; Sussman R; Winter C; McDaniel LD; Diamond M; Hart LS; Zhu S; Durbin AD; Abraham BJ; Anders L; Tian L; Zhang S; Wei JS; Khan J; Bramlett K; Rahman N; Capasso M; Iolascon A; Gerhard DS; Guidry Auvil JM; Young RA; Hakonarson H; Diskin SJ; Look AT; Maris JM
Nature; 2015 Dec; 528(7582):418-21. PubMed ID: 26560027
[TBL] [Abstract][Full Text] [Related]
34. Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians.
Shan J; Al-Rumaihi K; Rabah D; Al-Bozom I; Kizhakayil D; Farhat K; Al-Said S; Kfoury H; Dsouza SP; Rowe J; Khalak HG; Jafri S; Aigha II; Chouchane L
J Transl Med; 2013 May; 11():121. PubMed ID: 23668334
[TBL] [Abstract][Full Text] [Related]
35. Genetic variants and risk of prostate cancer using pathway analysis of a genome-wide association study.
Kim YS; Kim Y; Choi JW; Oh HE; Lee JH
Neoplasma; 2016; 63(4):629-34. PubMed ID: 27268928
[TBL] [Abstract][Full Text] [Related]
36. Genetic susceptibility to prostate cancer in Taiwan: A genome-wide association study.
Bau DT; Tsai CW; Chang WS; Yang JS; Liu TY; Lu HF; Wang YW; Tsai FJ
Mol Carcinog; 2024 Apr; 63(4):617-628. PubMed ID: 38390760
[TBL] [Abstract][Full Text] [Related]
37. A genome-wide survey over the ChIP-on-chip identified androgen receptor-binding genomic regions identifies a novel prostate cancer susceptibility locus at 12q13.13.
Feng J; Sun J; Kim ST; Lu Y; Wang Z; Zhang Z; Gronberg H; Isaacs WB; Zheng SL; Xu J
Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2396-403. PubMed ID: 21960693
[TBL] [Abstract][Full Text] [Related]
38. Genome-Wide 3'-UTR Single Nucleotide Polymorphism Association Study Identifies Significant Prostate Cancer Risk-Associated Functional Loci at 8p21.2 in Chinese Population.
Zhang N; Huang D; Jiang G; Chen S; Ruan X; Chen H; Huang J; Liu A; Zhang W; Lin X; Wu Y; Zhang Q; Li J; Tsu JH; Wei GH; Na R
Adv Sci (Weinh); 2022 Aug; 9(23):e2201420. PubMed ID: 35968571
[TBL] [Abstract][Full Text] [Related]
39. Multiple Functional Variants at 13q14 Risk Locus for Osteoporosis Regulate RANKL Expression Through Long-Range Super-Enhancer.
Zhu DL; Chen XF; Hu WX; Dong SS; Lu BJ; Rong Y; Chen YX; Chen H; Thynn HN; Wang NN; Guo Y; Yang TL
J Bone Miner Res; 2018 Jul; 33(7):1335-1346. PubMed ID: 29528523
[TBL] [Abstract][Full Text] [Related]
40. Functional annotation of risk loci identified through genome-wide association studies for prostate cancer.
Lu Y; Zhang Z; Yu H; Zheng SL; Isaacs WB; Xu J; Sun J
Prostate; 2011 Jun; 71(9):955-63. PubMed ID: 21541972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
